Brief: Affimed Appoints Shawn M. Leland As Chief Executive Officer
03/09/2024 13:39
Affimed NV A28A.F :
* AFFIMED APPOINTS SHAWN M. LELAND AS CHIEF EXECUTIVE
OFFICER
* AFFIMED NV - ANDREAS HARSTRICK, WHO HAS BEEN SERVING AS
ACTING
CEO SINCE JANUARY 2024 WILL CONTINUE IN HIS POSITION AS CHIEF
MEDICAL OFFICER
Source text for Eikon: ID:nGNX5kLzrG
Further company coverage: A28A.F
Recent news on Affimed NV
See all newsBrief: Affimed Announces Receipt Of Nasdaq Delisting Notice
Brief: Affimed Announces Receipt Of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
Brief: Affimed Reports Positive Clinical Update On Afm24/Atezolizumab Combination Therapy
Brief: Affimed NV Files For Common Stock Offering Of Up To $20 Million - SEC Filing
Brief: Affimed NV Files For Mixed Shelf Offering Of Up To $20 Million